AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value
ByAinvest
Friday, Aug 8, 2025 9:44 pm ET1min read
Chad Patterson, Chief Commercial Officer at iRhythm Technologies Inc, sold 2,555 shares of the company on August 6, 2025, according to a SEC filing. Following this transaction, Patterson now owns 43,667 shares of iRhythm Technologies Inc. The company specializes in cardiac monitoring and has seen more insider selling than buying over the past year. Patterson has sold a total of 28,761 shares and has not purchased any shares.
Chad Patterson, Chief Commercial Officer at iRhythm Technologies Inc., sold 2,555 shares of the company on August 6, 2025, according to a SEC filing. Following this transaction, Patterson now owns 43,667 shares of iRhythm Technologies Inc. The company specializes in cardiac monitoring and has seen more insider selling than buying over the past year. Patterson has sold a total of 28,761 shares and has not purchased any shares [1].iRhythm Technologies Inc. reported a quarterly revenue increase of 26.1%, reaching $186.69 million, and earnings per share of ($0.32), surpassing analyst expectations. The stock's current price is $160.99, with a market cap of $5.17 billion, and analysts maintain a consensus rating of "Moderate Buy" with a price target of $157.30 [1].
Analysts have shown a strong buy consensus for iRhythm Technologies Inc., with Truist Financial analyst Richard Newitter maintaining a Buy rating with a price target of $175.00. The company's market cap is $5.3B and has a P/E ratio of -56.19. However, corporate insider activity shows negative sentiment with an increase in insiders selling shares over the past quarter [2].
Despite the strong analyst sentiment and the company's impressive Q2 2025 performance, the negative insider activity may indicate concerns about the company's long-term trajectory. Investors should be mindful of this and consider the longer-term outlook of the business.
References:
[1] https://www.marketbeat.com/instant-alerts/irhythm-technologies-nasdaqirtc-insider-chad-patterson-sells-2555-shares-2025-08-07/
[2] https://www.ainvest.com/news/truist-financial-reiterates-buy-rating-irhythm-technologies-175-price-target-2508/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet